Extendicare (TSE:EXE) Hits New 12-Month High – Should You Buy?

Extendicare Inc. (TSE:EXEGet Free Report) shares hit a new 52-week high during mid-day trading on Friday . The company traded as high as C$24.96 and last traded at C$24.73, with a volume of 28917 shares trading hands. The stock had previously closed at C$24.66.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. TD Securities raised their price objective on shares of Extendicare from C$15.00 to C$19.00 in a report on Thursday, November 13th. Cormark boosted their price target on shares of Extendicare from C$25.00 to C$30.00 in a research report on Wednesday, December 3rd. BMO Capital Markets upgraded shares of Extendicare from a “hold” rating to an “outperform” rating and upped their price objective for the company from C$21.00 to C$24.00 in a research note on Thursday, December 4th. National Bank Financial lifted their target price on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Finally, Canaccord Genuity Group boosted their target price on Extendicare from C$20.00 to C$22.50 in a report on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of C$24.50.

Read Our Latest Research Report on EXE

Extendicare Price Performance

The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The company’s 50 day moving average is C$22.57 and its 200 day moving average is C$17.91. The stock has a market cap of C$2.36 billion, a price-to-earnings ratio of 23.58 and a beta of 1.30.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Stories

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.